Van ECK Associates Corp increased its stake in Solventum Co. (NYSE:SOLV - Free Report) by 28.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 47,224 shares of the company's stock after purchasing an additional 10,530 shares during the quarter. Van ECK Associates Corp's holdings in Solventum were worth $3,120,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Modus Advisors LLC purchased a new stake in Solventum in the 4th quarter worth $25,000. Stonebridge Financial Group LLC purchased a new stake in Solventum in the 4th quarter worth $26,000. True Wealth Design LLC increased its stake in Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company's stock worth $33,000 after buying an additional 471 shares in the last quarter. Crews Bank & Trust purchased a new stake in Solventum in the 4th quarter worth $32,000. Finally, Prospera Private Wealth LLC purchased a new position in shares of Solventum during the third quarter valued at about $35,000.
Wall Street Analyst Weigh In
A number of research analysts have recently weighed in on the company. Morgan Stanley raised their price objective on Solventum from $60.00 to $73.00 and gave the company an "equal weight" rating in a research report on Monday, November 11th. Mizuho assumed coverage on Solventum in a research report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 price objective for the company. Finally, Piper Sandler raised their price objective on Solventum from $71.00 to $75.00 and gave the company a "neutral" rating in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $68.29.
Get Our Latest Report on Solventum
Solventum Stock Down 1.9 %
SOLV traded down $1.42 on Friday, hitting $73.08. The company had a trading volume of 570,685 shares, compared to its average volume of 891,579. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The business's fifty day simple moving average is $71.07 and its 200 day simple moving average is $68.95.
Solventum Profile
(
Free Report)
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.
Featured Stories
Before you consider Solventum, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Solventum wasn't on the list.
While Solventum currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
